Contents

Search

avatrombopag (Doptelet)

Indications: - thrombocytopenia in patient with chronic liver disease who are to undergo a planned medical or dental procedure Mechanism of action: - thrombopoietin receptor agonist - stimulates platelet production

General

thrombopoietin receptor agonist

References

  1. Brooks M FDA OKs Platelet Booster for Liver Disease Patients . Medscape - May 21, 2018 https://www.medscape.com/viewarticle/897029